Investors need to be somewhat risk-tolerant if they wish to invest in penny stocks. However, the rewards could sometimes be enormous, and hence, it is important to keep an eye on the news at all times. There have been some companies in this category that have been in the news in recent times. Here is a quick look at four such companies:
Epazz, Inc. (OTC: EPAZ) It’s a new dawn for Epazz, a mission-critical provider of drone technology, cryptocurrency technology, and cloud-based business software solutions. On August 16, 2023, the company delivered impressive second-quarter results driven by robust demand for its artificial intelligence-powered cloud solutions. Revenue in the quarter was up by 13% to $580,530, with EBITDA increasing 71.8% to $37,372.
The impressive results were driven by the use of artificial intelligence engines in the company’s cloud business software products. The products remain the key driver of the company’s bottom line as Epazz continues to upgrade its technology with AI engines to assist customers with better ways of operating.
Looking ahead, Epazz is anticipating new sources of revenue backed by its game-changing drone technology and smart glasses. ZenaDrone 1000 is the company’s flagship drone technology that is eliciting strong interest for use in agriculture, healthcare, and military operations. As drones continue to capture the imagination of consumers, businesses, and governments worldwide, the company has positioned itself to take advantage of the massive market opportunity.
The company has already received positive feedback from industries such as the military, agriculture, oil and gas wildfire management, and civil engineering thanks to its drone technology’s advanced features. Consequently, Epazz has already started pursuing commercial applications and negotiating to provide precision agriculture drones to Irish farmers. It’s in the process of manufacturing over 30 drones, including 20 drones as a service in Ireland.
On August 10, 2023, Epazz Holdings secured much-needed funding to make its ZenaDrone 1000 readily available for Houston, Texas’s oil and gas industry. The drones are expected to play a pivotal role in replacing heavy, expensive helicopters often used for delivery and inspections. The company is already in discussions with major oil companies about the use of drones to deliver machine parts to refineries and offshore oil grids.
In addition to pursuing opportunities for growth in the US, Epazz has also set sights on emerging opportunities abroad. On August 24, it confirmed it is in the process of finalizing a joint venture in Brazil to establish a facility for ZenaDrone 1000 operations.
The setting up of the facility comes via drone, eliciting strong interest from over 25 esteemed Brazilian organizations. The company has already started integrating the Portuguese language option into the drones to ensure seamless communication and accessibility.
CEO Shaun Passley, Ph.D., said, “We are expanding via international joint ventures. We are also working on South Africa and India joint ventures.”
The strategic move is expected to yield over $150,000 per drone annually. Likewise, Epazz is also looking to make its drones available in South Africa and India as part of its expansion drive.
SunHydrogen Inc. (OTC: HYSR) The company is involved in the development of path-breaking technologies for the purpose of synthesizing, using, and storing green hydrogen. As per estimates from investment banking behemoth Goldman Sachs, the market SunHydrogen Inc. is involved in could be worth as much as $12 trillion by 2050.
SunHydrogen is working on the development of its patented SunHydrogen Panel technology, which could use sunlight and any source of water to produce cost-effective hydrogen. The company’s panels would produce hydrogen in the same way solar panels produce solar energy.
On August 29, SunHydrogen provided an update to its shareholders through a letter from its Chief Executive Officer, Tim Young. The CEO started off by noting that amidst the threat of climate change at a global level, the company was committed to helping the world move into a future that could be emission-free. He noted that panel technology had consistently managed to produce commercial-scale procurement densities and photovoltages at a lab scale. As a consequence, the company inked a Memorandum of Understanding with the firm COTEC to produce lab-scale production for the company through the deployment of industrial electroplating methodologies.
The initial electroplating process, in collaboration with COTEC, is expected to be completed by December 31 this year. Once that particular phase is concluded, SunHydrogen would produce hydrogen panels spanning 1 square meter, which would then be deployed in a number of pilot projects.
The pilot projects would provide a look into nanoparticle-powered commercial-scale green energy hydrogen production for the first time in the world. COTEC is based out of Changwon, South Korea, and is a leading player in the electrochemical and electroplating processes. It was further noted that COTEC was in a strong position to collaborate on the key project.
Elite Pharmaceuticals Inc. (OTC: ELTP) is a specialty pharmaceutical company focused on the manufacturing, development, and distribution of generic products of a niche nature. The product lines offered by Elite Pharmaceuticals Incare are made up of controlled-release and immediate-release solid oral dose products. The products are marketed by the company under the Elite Laboratories brand.
Additionally, the products are also sold through licenses provided to third-party pharmaceutical distribution and marketing entities. The company runs a DEA and cGMP-registered facility that is deployed for the development, research, and manufacturing of its products. It is located in Northvale, New Jersey.
On August 28, Elite Pharmaceuticals announced positive results from the key fed and fasted bioequivalence studies pertaining to a generic, but as yet undisclosed, product that fell under the classification of CNS stimulants. In this context, it ought to be noted that IQVIA reported the annual sales for the generic and branded category market for the product in the 12 months ending June 2023 at $5.1 billion. The studies that had been conducted by the company were randomized, open-label, two-sequence, single oral dose, balanced, two-treatment, two-period, and two-way crossover comparative bioavailability studies.
The studies were conducted on healthy and adult human subjects under both fasting and feeding conditions. The company noted in its news release that the results demonstrated that the generic product was a bioequivalent of the branded product. Elite Pharmaceuticals stated that it was working on the compilation of the data related to the product so that it could make an abbreviated new drug application with the United States Food and Drug Administration.
American Battery Technology Company (OTC: ABML): The company, which was earlier known as American Battery Technology Corporation, is in a distinctive position to provide low environmental impact, low cost, and domestically procured battery metals by way of its three divisions.
The three divisions in question are concerned with primary resource development, lithium-ion battery recycling, and primary battery metal extraction technologies.
On August 29, American Battery Technology Company hit a targeted core drilling depth of as much as 1430 feet at one of the deepest lithium sampling areas situated in Smoky Valley. The drilling initiative was part of the company’s objective to take the Tonopah Flats Lithium Project forward.
In the news release, American Battery Technology noted that it had managed to complete four out of the eight holes, which had been part of the step-out drilling and infill sampling efforts. The drill program also supported the possibility of developing a domestic resource, which could assist in upgrading the indicated and measured resource classification.
“We are extremely proud of our team in Tonopah with this accomplishment, as we now have identified the Upper, Middle, and Lower Siebert formation geologically in the basin, all within a single hole,” stated Scott Jolcover, Chief Mineral Resources Officer.
The previous deepest hole that had been drilled by the company stood at 866 feet. American Battery Technology’s Tonopah Flats Lithium Project spans across 517 unpatented lode claims and covers 10340 acres. The company owns the entirety of the rights to all the lode claims and all the minerals therein, without any royalty-related liabilities.
Disclaimers:CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) is owned by RazorPitch Inc. and has been retained by Epazz Inc. to assist in the production and distribution of content. ‘CGR’ is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport/RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR/RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Please visit CapitalGainsReport.com/Disclaimer for full disclaimer.